菜单
Recently, Boji Medical Technology Co., Ltd. (hereinafter referred to as “Boji Medical”) and JP Medical Consulting Pty Ltd of Australia (hereinafter referred to as “JP Medical Consulting”) officially announced the establishment of a strategic partnership. This collaboration will integrate the clinical resources and professional strengths of both parties in the China–Australia pharmaceutical field, provide Chinese…
阅读文章
Queensland has long been an ideal destination for early-phase clinical trials. On May 20, the Shanghai–Queensland Biopharmaceutical Industry Development Seminar was successfully held at the Medical Device Innovation Center in the Lin-gang Special Area of Shanghai. The event brought together dozens of professionals from the biomedicine sector. Discussions focused on key topics such as Queensland’s…
阅读文章
On May 20, Xiying (Shanghai) Medical Technology Co., Ltd. (hereinafter referred to as “Xiying Medical”) and JP Medical Consulting Pty Ltd. of Australia (hereinafter referred to as “JP Medical Consulting”) officially signed a strategic cooperation agreement at the National Innovation Park of East China University of Science and Technology in Shanghai. The two parties will…
阅读文章
The Australia Pavilion at the 2025 DIA China Annual Meeting is hosted by the Commercial Section of the Australian Embassy and Consulates in China, together with the Australian Trade and Investment Commission (Austrade). It serves as a key platform to showcase Australia’s strengths in clinical trials and biotechnology. We invite you to visit Booth L16…
阅读文章
On August 20, following the strategic partnership between the two companies a few weeks ago, Ms. Helen Dai, Consul General of Australia in Chengdu and Head of Austrade, led a government team to visit Stam’s Shanghai office. Yu Wenhao, Senior Vice President and CBO of Stam Pharmaceutical, and Bao Yuanwu, General Manager of Shanghai and…
阅读文章
On July 24, Stam Pharmaceuticals (Beijing) Co., Ltd. (hereinafter referred to as “Stam Pharmaceuticals”) and JP Medical Consulting Pty Ltd (hereinafter referred to as “JP Medical Consulting”) of Australia announced a strategic cooperation. The cooperation aims to make full use of the clinical resources and professional advantages of both parties in the field of medicine…
阅读文章
In order to strengthen academic exchanges and cooperation with top international medical teams and promote high-quality development of disciplines, the Department of Obstetrics and Gynecology of the Second Affiliated Hospital of Chongqing Medical University invited Professor Mark von ltzstein, a fellow of the Royal Australian Institute of Chemistry, a fellow of the Australian Academy of…
阅读文章
From May 16 to 19, 2024, the Australian Trade and Investment Commission (Austrade) led a delegation of 16 leading Australian clinical trial providers to the DIA China Annual Meeting 2024, showcasing Australia’s strengths and services in drug development, technological innovation, and clinical trials. As one of 16 Australian companies, JP Medical Consulting made its debut…
阅读文章
Professor Mark von Itzstein, JP Medical Consultant, Fellow of the Australian Academy of Science, and Dr. James Pang, CEO of JP Medical Consulting, have been appointed as honorary and visiting professors of Chongqing Medical University. 推进国际合作 澳大利亚皇家化学研究所院士受聘重庆医科大学荣誉教授 大咖来了！国际顶级学者受聘重医荣誉教授
阅读文章